Effects of silodosin and tamsulosin on the urethra and cardiovascular system in young and old dogs with benign prostatic hyperplasia

European Journal of Pharmacology

Volumn 613, Issue 1-3, 2009, Pages 135-140

  Kobayashi, Shinya ^a   Tomiyama, Yoshitaka ^a   Tatemichi, Satoshi ^a   Hoyano, Yuji ^a   Kobayashi, Mamoru ^a   Yamazaki, Yoshinobu ^a  

^a KISSEI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

1 Adrenoceptor; Aging; Benign prostatic hyperplasia; Silodosin

Indexed keywords

ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1D ADRENERGIC RECEPTOR; SILODOSIN; TAMSULOSIN;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CARDIOVASCULAR SYSTEM; CONTROLLED STUDY; DOG; DRUG DOSE INCREASE; DRUG EFFICACY; HISTOPATHOLOGY; HYPOGASTRIC NERVE; HYPOTENSION; MALE; MEAN ARTERIAL PRESSURE; MICROSCOPY; NERVE STIMULATION; NONHUMAN; ORGAN WEIGHT; PALPATION; PRIORITY JOURNAL; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; URETHRA PRESSURE;

ADRENERGIC ALPHA-ANTAGONISTS; AGING; ANIMALS; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; DOGS; HEART RATE; INDOLES; MALE; ORGAN SIZE; PRESSURE; PROSTATE; PROSTATIC HYPERPLASIA; SULFONAMIDES; URETHRA;

EID: 65749098620     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.04.030     Document Type: Article

References (26)

1. Andros E., Detmar-Hanna D., Supteparuk S., Gal J., and Gerber J.G. The effect of aging on the pharmacokinetics and pharmacodynamics of prazosin. Eur. J. Clin. Pharmacol. 50 (1996) 41-46
2. Brendler C.B., Berry S.J., Ewing L.L., McCullough A.R., Cochran R.C., Strandberg J.D., Zirkin B.R., Coffey D.S., Wheaton L.G., Hiler M.L., Bordy M.J., Niswender G.D., Scott W.W., and Walsh P.C. Spontaneous benign prostatic hyperplasia in the beagle. Age-associated changes in serum hormone levels, and the morphology and secretory function of the canine prostate. J. Clin. Invest. 71 (1983) 1114-1123
3. Cavalli A., Lattion A.L., Hummler E., Nenniger M., Pedrazzini T., Aubert J.F., Michel M.C., Yang M., Lembo G., Vecchione C., Mostardini M., Schmidt A., Beermann F., and Cotecchia S. Decreased blood pressure response in mice deficient of the alpha 1b-adrenergic receptor. Proc. Natl. Acad. Sci. USA 94 (1997) 11589-11594
4. Chapple C.R. A comparison of varying alpha-blockers and other pharmacotherapy options for lower urinary tract symptoms. Rev. Urol. 7 (2005) S22-30
5. 1A receptors in the control of the micturition reflex in male anaesthetized rats. Br. J. Pharmacol. 133 (2001) 61-72
6. Evans H.E., and Christensen G.C. Miller's Anatomy of the Dog. 7th ed. (1979), W B Saunders, Philadelphia
7. Hancock A.A., Buckner S.A., Brune M.E., Esbenshade T.A., Ireland L.M., Katwala S., Milicic I., Meyer M.D., Kerwin Jr. J.F., and Williams M. Preclinical pharmacology of fiduxosin, a novel alpha 1-adrenoceptor antagonist with uroselective properties. J. Pharmacol. Exp. Ther. 300 (2002) 478-486
8. 1-adrenoceptor subtypes mediating the contraction of human prostatic urethra and peripheral artery. Br. J. Pharmacol. 113 (1994) 723-728
9. Kenny B.A., Naylor A.M., Carter A.L., Read A.M., Greengrass P.M., and Wyllie M.G. Effect of alpha 1 adrenoceptor antagonists on prostatic pressure and blood pressure in the anesthetized dog. Urology 44 (1994) 52-57
10. Lepor H. Medical therapy for benign prostatic hyperplasia. Urology 42 (1993) 483-501
11. Lluel P., Deplanne V., Heudes D., Bruneval P., and Palea S. Age-related changes in urethrovesical coordination in male rats: relationship with bladder instability?. Am. J. Physiol., Regul. Integr. Comp. Physiol. 284 (2003) R1287-R1295
12. Lowseth L.A., Gerlach R.F., Gillett N.A., and Muggenburg B.A. Age-related changes in the prostate and testes of the beagle dog. Vet. Pathol. 27 (1990) 347-353
13. Marshall I., Burt R.P., and Chapple C.R. Noradrenaline contractions of human prostate mediated by alpha 1A-(alpha 1c-) adrenoceptor subtype. Br. J. Pharmacol. 115 (1995) 781-786
14. 2- and β-adrenoceptors in the urinary bladder, urethra and prostate. Br. J. Pharmacol. 147 (2006) S88-S119
15. Monda J.M., and Oesterling J.E. Medical treatment of benign prostatic hyperplasia: 5 alpha-reductase inhibitors and alpha-adrenergic antagonists. Mayo Clin. Proc. 68 (1993) 670-679
16. Murakoshi M., Ikeda R., and Fukui N. The effects of chlormadinone acetate (CMA), antiandrogen, on the pituitary, testis, prostate and adrenal gland of the dog with spontaneous benign prostatic hyperplasia. J. Toxicol. Sci. 26 (2001) 119-127
17. Murata S., Taniguchi T., Takahashi M., Okada K., Akiyama K., and Muramatsu I. Tissue selectivity of KMD-3213, an alpha 1-adrenoceptor antagonist, in human prostate and vasculature. J. Urol. 164 (2000) 578-583
18. 1-adrenoceptor antagonists on intraurethral pressure in the prostatic urethra and intraluminal pressure in the vas deferens in male dogs. Eur. J. Pharmacol. 580 (2008) 256-261
19. Ramage A.G., and Wyllie M.G. A comparison of the effects of doxazosin and terazosin on the spontaneous sympathetic drive to the bladder and related organs in anaesthetized cats. Eur. J. Pharmacol. 294 (1995) 645-650
20. 1-adrenergic receptors by vessel bed and age. Circulation 100 (1999) 2336-2343
21. 1-adrenoceptor responsiveness in female beagle dogs. J. Urol. 156 (1996) 1485-1488
22. Take H., Shibata K., Awaji T., Hirasawa A., Ikegaki I., Asano T., Takada T., and Tsujimoto G. Vascular alpha 1-adrenoceptor subtype selectivity and alpha 1-blocker-induced orthostatic hypotension. Jpn. J. Pharmacol. 77 (1998) 61-70
23. 1-Adrenoceptor subtype selectivity and organ specificity of silodosin (KMD-3213). Yakugaku Zasshi 126 (2006) 209-216
24. Tatemichi S., Tomiyama Y., Maruyama I., Kobayashi S., Kobayashi K., Maezawa A., Kobayashi M., Yamazaki Y., and Shibata N. Uroselectivity in male dogs of Silodosin (KMD-3213), a novel drug for the obstructive component of benign prostatic hyperplasia. Neurourol. Urodyn. 25 (2006) 792-799
25. Townsend S.A., Jung A.S., Hoe Y.S., Lefkowitz R.Y., Khan S.A., Lemmon C.A., Harrison R.W., Lee K., Barouch L.A., Cotecchia S., Shoukas A.A., Nyhan D., Hare J.M., and Berkowitz D.E. Critical role for the α-1B adrenergic receptor at the sympathetic neuroeffector junction. Hypotension 44 (2004) 776-782
26. Wilson J.D. The pathogenesis of benign prostatic hyperplasia. Am. J. Med. 68 (1980) 745-756